STUDY OF THE RELATIVE SAFETY AND EFFICACY OF COLLAGENASE THERAPY

胶原酶疗法的相对安全性和功效的研究

• 批准号: 7607857
• 负责人: LAWRENCE C HURST
• 金额: $ 0.59万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-03-23 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607857
• 关键词: Affect; Computer Retrieval of Information on Scientific Projects Database; Contracture; Disease; Fingers; Funding; Grant; Injection of therapeutic agent; Institution; Pharmaceutical Preparations; Phase; Purpose; Relative (related person); Research; Research Personnel; Resources; Rupture; Safety; Source; Testing; Tissues; United States National Institutes of Health; collagenase

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the study is to test whether an experimental drug called collagenase will disolve and rupture the tissue causing the contracture of your finger(s)due to your Dupuytren's disease. If your finger has failed to respond to injection after three random injections, or if you still have other fingers affected by Dupuytren's disease after three random injections, you are eligible to participate in an extended phase of the study.

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是测试一种名为胶原酶的实验性药物是否会溶解和破裂因杜普伊特伦病而导致手指(S)痉挛的组织。如果你的手指在三次随机注射后对注射没有反应，或者如果你在三次随机注射后仍有其他手指受到Dupuytren病的影响，你有资格参加延长阶段的研究。